Pharmaceutical Packaging Market Size, Trends and Insights By Type (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Material (Plastics and Polymer, Paper & Paperboard, Glass, Aluminum Foil, Others), By Drug Delivery System (Oral Drugs, Injectables, Topical, Ocular/ Ophthalmic, Nasal, Pulmonary, Transdermal, Others (IV Drugs, etc.)), By End Use (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Institutional Pharmacy), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Amcor plc
- AptarGroup Inc.
- Becton
- Berry Global Inc.
- CCL Industries Inc
- Comar LLC
- Others
Reports Description
Global Pharmaceutical Packaging Market was valued at USD 135.2 Billion in 2023 and is expected to reach USD 284.0 Billion by 2032, at a CAGR of 7.72% during the forecast period 2023 – 2032.
Pharmaceutical packaging is used to store and protect drugs. It is also essential for identification purposes, marketing and promotion of different brands, and for facilitating the use of pharmaceutical products. There are different types of pharmaceutical packaging classified as primary, secondary, and tertiary.
Primary drug packaging is the material that surrounds the pharmaceutical product, while secondary and tertiary packaging provide additional external protection.
Pharmaceutical Packaging Market: Growth Factors
The rapidly expanding pharmaceutical industry across the globe is mainly driving the pharmaceutical packaging market. The rising demand for pharmaceutical goods due to the increasing aging population, growing incidences of chronic diseases, and advances in medical treatment are expected to propel the demand for efficient packaging to enable the safety and security of pharmaceutical drugs and pharma goods.
Pharmaceutical packaging protects the contents of a product from spoilage, breakage, leakage, etc. Increasing focus on healthcare and rising healthcare infrastructure across the globe is expected to boost the demand for pharmaceutical drugs and goods, thereby driving market growth.
For instance, in Organization for Economic Cooperation and Development (OECD) nations, the consumption of cholesterol-lowering medications has almost tripled, the use of antidepressants has doubled, and the consumption of antihypertensive and antidiabetic pharmaceuticals has nearly doubled.
As economies flourished and medical supply and insurance systems expanded, which in turn boosted the demand for both domestic and foreign pharmaceuticals, thereby driving the demand for pharmaceutical packaging.
Furthermore, the increasing consumption and production of pharmaceutical drugs and the growing demand for protection, preservation, storage and transportation of these drugs and medicines are also boosting the market growth.
Growing technological advancements are boosting the pharmaceutical and healthcare industry across the globe, which in turn boosts the demand for pharmaceutical packaging such as bottles, vials, and other packaging solutions.
Additionally, the growing demand for Injectables, generic and branded medicines is driving the growth of glass vials, and blister packaging in the pharmaceutical industry. Increasing demand for oncology and other high-potency drugs such as antibody conjugates and fast-acting steroids due to the increasing prevalence of various diseases is expected to propel the demand for pharmaceutical packaging.
Pharmaceutical Packaging Market: Restraints
Various factors such as stringent regulations, lack of universal directives about the usage of pharmaceutical packaging, fluctuation in raw material prices and lack of access to proper healthcare infrastructure in many underdeveloped economies are some of the factors restraining the market growth.
Every country has different regulations about the usage of pharmaceutical packaging, companies find it very difficult to cope with such country wide regulations, which in turn restrain investment in the market, thereby restraining market growth.
Time consuming drug approval processes and extended timelines are causing delays in new drug production and pharmaceutical packaging, which in turn increases the counterfeiting of packaging, thereby creating challenges for market growth.
Furthermore, factors such as financial constraints, inadequate infrastructure, low literacy rates in many underdeveloped countries and outdated healthcare equipment’s restraining the growth of healthcare and pharmaceutical industries in many developing and underdeveloped countries, which in turn restraining the pharmaceutical packaging market.
Pharmaceutical Packaging Market: Opportunities
Growing Demand for Primary Pharmaceutical Packaging
Increasing usage of primary pharmaceutical packaging in generic and branded pharmaceutical drugs is expected to create lucrative opportunities for market growth during the forecast period. Many pharmaceutical products can be compromised by environmental factors like light or air.
A compromised pharmaceutical product may fail to perform its intended function, leading to dangerous consequences for patients. Primary packaging plays a critical role in combating external elements, preventing chemical alterations and thus preserving the efficacy of medications.
Pharmaceutical Packaging Market: Segmentation Analysis
The Global Pharmaceutical Packaging market is segmented by type, by material, by drug delivery system, by end use and by region.
By Type, the global pharmaceutical packaging market is segmented into primary packaging, secondary packaging, and tertiary packaging. Among all of these segments, primary packaging held the highest market share in 2022 and is expected to keep its dominance during the forecast period.
Primary packaging type is the material that first envelops the product and holds it i.e., those package components and subcomponents that come in contact with the product and have a direct effect on the product shelf-life. Examples of primary packaging include ampoules and vials, prefilled syringes, IV containers, blister packs, etc.
Secondary packaging type is expected to hold substantial market share during the forecast period. Secondary packaging is outside the primary packaging and used to group primary packages together. Examples of secondary packaging includes cartons, boxes, shipping containers, injection trays, etc. Tertiary packaging system is used for bulk handling and shipping e.g., barrel, container, edge protectors, etc.
By material, the global pharmaceutical packaging market is segmented into plastics and polymer, paper & paperboard, glass, aluminium foil and others. Among all of these materials, plastics and polymer materials held the highest market share in 2022 and are expected to keep their dominance during the forecast period.
Plastics and Polymers material is most preferred materials by pharmaceutical packaging manufacturers because it is permeable to moisture, oxygen and carbon dioxide. Growing use of plastic and polymer material in blister packaging, OTC drugs, prefilled syringes and generic drugs.
By Drug delivery system, Oral Drugs held the highest market share in 2022 and are expected to keep their dominance during the forecast period. Oral drugs play a crucial role in the pharmaceutical industry by ensuring the safe and effective administration of medications.
By end use, the Pharma Manufacturing segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period. Factors such as growing global demand for generics, rising potential for pharmaceutical manufacturing worldwide, and growing implementation of supportive policies are expected to drive the market growth of this segment during the forecast period.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 135.2 Billion |
| Projected Market Size in 2032 | USD 284 Billion |
| Market Size in 2022 | USD 126 Billion |
| CAGR Growth Rate | 7.72% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Material, Drug Delivery System, End Use and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Pharmaceutical Packaging Market: Regional Analysis
By region, Pharmaceutical Packaging market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Among all of these regions, North America held the highest market share of 37.26% in 2022 and is expected to keep its dominance during the forecast period.
The presence of a large number of manufacturers of pharmaceutical plastic bottles in the U.S. and Canada coupled with a well-established pharmaceutical manufacturing industry in the region.
Furthermore, factors such as rising healthcare spending in the U.S. and Canada and increasing supportive policies for pharmaceutical and healthcare industry in the region are expected to create lucrative opportunities for the market during the forecast period.
Asia Pacific is expected to hold a significant market share during the forecast period. Rapidly expanding healthcare and pharmaceutical industries in China, India, Japan, ASEAN, South Korea and Australia are expected to propel the market growth in this region.
China dominated the Asia Pacific market owing to the presence of well-established supply chain, easy availability of raw materials, and rapidly expanding healthcare and pharmaceutical industries. India is expected to grow at a significant growth rate during the forecast period because it is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume.
India also has the highest number of US-FDA compliant Pharma plants outside of the USA and is home to more than 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities as well as a highly skilled resource pool. Such factors are expected to drive the market growth of this region during the forecast period.
Europe is expected to hold a significant market share during the forecast period. Major economies such as France, U.K, Germany, Spain, and Russia are expected to create lucrative opportunities for the market during the forecast period owing to the availability of a skilled workforce, well developed pharma and healthcare industries.
Pharmaceutical Packaging Market: Recent Developments
- In April 2022, Amcor, a global leader in responsible packaging solutions launched new more sustainable High Shield laminates to its pharma packaging portfolio. The new low carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements. Through these new sustainable product launches, Amcor is supporting pharmaceutical companies’ recyclability agendas.
- In February 2024, Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines.
- In February 2024, Amcor scales up thermoforming production capacity in North America. Through this expansion, Amcor will address the increasing demand in the medical, pharmaceutical, and consumer health sectors.
List of the prominent players in the Pharmaceutical Packaging Market:
- Amcor plc
- AptarGroup Inc.
- Becton
- Berry Global Inc.
- CCL Industries Inc
- Comar LLC
- Dickinson and Company
- Drug Plastics Group
- Gerresheimer AG
- International Paper
- Owens Illinois Inc.
- Schott AG
- SGD Pharma
- Vetter Pharma International
- West Pharmaceutical Services Inc.
- WestRock Company
- Others
The Pharmaceutical Packaging Market is segmented as follows:
By Type
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
By Material
- Plastics and Polymer
- Paper & Paperboard
- Glass
- Aluminum Foil
- Others
By Drug Delivery System
- Oral Drugs
- Injectables
- Topical
- Ocular/ Ophthalmic
- Nasal
- Pulmonary
- Transdermal
- Others (IV Drugs, etc.)
By End Use
- Pharma Manufacturing
- Contract Packaging
- Retail Pharmacy
- Institutional Pharmacy
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Pharmaceutical Packaging Market, (2024 – 2033) (USD Billion)
- 2.2 Global Pharmaceutical Packaging Market: snapshot
- Chapter 3. Global Pharmaceutical Packaging Market – Industry Analysis
- 3.1 Pharmaceutical Packaging Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing population
- 3.2.2 Rising Disposable Income
- 3.2.3 Growing focus on increasing life expectancy.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Material
- 3.7.3 Market Attractiveness Analysis By Drug Delivery System
- 3.7.4 Market Attractiveness Analysis By End Use
- Chapter 4. Global Pharmaceutical Packaging Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pharmaceutical Packaging Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pharmaceutical Packaging Market – Type Analysis
- 5.1 Global Pharmaceutical Packaging Market Overview: By Type
- 5.1.1 Global Pharmaceutical Packaging Market Share, By Type, 2022 and – 2033
- 5.2 Primary Packaging
- 5.2.1 Global Pharmaceutical Packaging Market by Primary Packaging, 2024 – 2033 (USD Billion)
- 5.3 Secondary Packaging
- 5.3.1 Global Pharmaceutical Packaging Market by Secondary Packaging, 2024 – 2033 (USD Billion)
- 5.4 Tertiary Packaging
- 5.4.1 Global Pharmaceutical Packaging Market by Tertiary Packaging, 2024 – 2033 (USD Billion)
- 5.1 Global Pharmaceutical Packaging Market Overview: By Type
- Chapter 6. Global Pharmaceutical Packaging Market – Material Analysis
- 6.1 Global Pharmaceutical Packaging Market Overview: By Material
- 6.1.1 Global Pharmaceutical Packaging Market Share, By Material, 2022 and – 2033
- 6.2 Plastics and Polymer
- 6.2.1 Global Pharmaceutical Packaging Market by Plastics and Polymer, 2024 – 2033 (USD Billion)
- 6.3 Paper & Paperboard
- 6.3.1 Global Pharmaceutical Packaging Market by Paper & Paperboard, 2024 – 2033 (USD Billion)
- 6.4 Glass
- 6.4.1 Global Pharmaceutical Packaging Market by Glass, 2024 – 2033 (USD Billion)
- 6.5 Aluminum Foil
- 6.5.1 Global Pharmaceutical Packaging Market by Aluminum Foil, 2024 – 2033 (USD Billion)
- 6.6 Others
- 6.6.1 Global Pharmaceutical Packaging Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Pharmaceutical Packaging Market Overview: By Material
- Chapter 7. Global Pharmaceutical Packaging Market – Drug Delivery System Analysis
- 7.1 Global Pharmaceutical Packaging Market Overview: By Drug Delivery System
- 7.1.1 Global Pharmaceutical Packaging Market Share, By Drug Delivery System, 2022 and – 2033
- 7.2 Oral Drugs
- 7.2.1 Global Pharmaceutical Packaging Market by Oral Drugs, 2024 – 2033 (USD Billion)
- 7.3 Injectables
- 7.3.1 Global Pharmaceutical Packaging Market by Injectables, 2024 – 2033 (USD Billion)
- 7.4 Topical
- 7.4.1 Global Pharmaceutical Packaging Market by Topical, 2024 – 2033 (USD Billion)
- 7.5 Ocular/ Ophthalmic
- 7.5.1 Global Pharmaceutical Packaging Market by Ocular/ Ophthalmic, 2024 – 2033 (USD Billion)
- 7.6 Nasal
- 7.6.1 Global Pharmaceutical Packaging Market by Nasal, 2024 – 2033 (USD Billion)
- 7.7 Pulmonary
- 7.7.1 Global Pharmaceutical Packaging Market by Pulmonary, 2024 – 2033 (USD Billion)
- 7.8 Transdermal
- 7.8.1 Global Pharmaceutical Packaging Market by Transdermal, 2024 – 2033 (USD Billion)
- 7.9 Others (IV Drugs, etc.)
- 7.9.1 Global Pharmaceutical Packaging Market by Others (IV Drugs, etc.), 2024 – 2033 (USD Billion)
- 7.1 Global Pharmaceutical Packaging Market Overview: By Drug Delivery System
- Chapter 8. Global Pharmaceutical Packaging Market – End Use Analysis
- 8.1 Global Pharmaceutical Packaging Market Overview: By End Use
- 8.1.1 Global Pharmaceutical Packaging Market Share, By End Use, 2022 and – 2033
- 8.2 Pharma Manufacturing
- 8.2.1 Global Pharmaceutical Packaging Market by Pharma Manufacturing, 2024 – 2033 (USD Billion)
- 8.3 Contract Packaging
- 8.3.1 Global Pharmaceutical Packaging Market by Contract Packaging, 2024 – 2033 (USD Billion)
- 8.4 Retail Pharmacy
- 8.4.1 Global Pharmaceutical Packaging Market by Retail Pharmacy, 2024 – 2033 (USD Billion)
- 8.5 Institutional Pharmacy
- 8.5.1 Global Pharmaceutical Packaging Market by Institutional Pharmacy, 2024 – 2033 (USD Billion)
- 8.1 Global Pharmaceutical Packaging Market Overview: By End Use
- Chapter 9. Pharmaceutical Packagings Market – Regional Analysis
- 9.1 Global Pharmaceutical Packagings Market Regional Overview
- 9.2 Global Pharmaceutical Packagings Market Share, by Region, 2022 & – 2033 (USD Billion)
- 9.3. North America
- 9.3.1 North America Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.3.1.1 North America Pharmaceutical Packagings Market, by Country, 2024 – 2033 (USD Billion)
- 9.3.1 North America Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.4 North America Pharmaceutical Packagings Market, by Type, 2024 – 2033
- 9.4.1 North America Pharmaceutical Packagings Market, by Type, 2024 – 2033 (USD Billion)
- 9.5 North America Pharmaceutical Packagings Market, by Material, 2024 – 2033
- 9.5.1 North America Pharmaceutical Packagings Market, by Material, 2024 – 2033 (USD Billion)
- 9.6 North America Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033
- 9.6.1 North America Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033 (USD Billion)
- 9.7 North America Pharmaceutical Packagings Market, by End Use, 2024 – 2033
- 9.7.1 North America Pharmaceutical Packagings Market, by End Use, 2024 – 2033 (USD Billion)
- 9.8. Europe
- 9.8.1 Europe Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.8.1.1 Europe Pharmaceutical Packagings Market, by Country, 2024 – 2033 (USD Billion)
- 9.8.1 Europe Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.9 Europe Pharmaceutical Packagings Market, by Type, 2024 – 2033
- 9.9.1 Europe Pharmaceutical Packagings Market, by Type, 2024 – 2033 (USD Billion)
- 9.10 Europe Pharmaceutical Packagings Market, by Material, 2024 – 2033
- 9.10.1 Europe Pharmaceutical Packagings Market, by Material, 2024 – 2033 (USD Billion)
- 9.11 Europe Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033
- 9.11.1 Europe Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033 (USD Billion)
- 9.12 Europe Pharmaceutical Packagings Market, by End Use, 2024 – 2033
- 9.12.1 Europe Pharmaceutical Packagings Market, by End Use, 2024 – 2033 (USD Billion)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.13.1.1 Asia Pacific Pharmaceutical Packagings Market, by Country, 2024 – 2033 (USD Billion)
- 9.13.1 Asia Pacific Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.14 Asia Pacific Pharmaceutical Packagings Market, by Type, 2024 – 2033
- 9.14.1 Asia Pacific Pharmaceutical Packagings Market, by Type, 2024 – 2033 (USD Billion)
- 9.15 Asia Pacific Pharmaceutical Packagings Market, by Material, 2024 – 2033
- 9.15.1 Asia Pacific Pharmaceutical Packagings Market, by Material, 2024 – 2033 (USD Billion)
- 9.16 Asia Pacific Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033
- 9.16.1 Asia Pacific Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033 (USD Billion)
- 9.17 Asia Pacific Pharmaceutical Packagings Market, by End Use, 2024 – 2033
- 9.17.1 Asia Pacific Pharmaceutical Packagings Market, by End Use, 2024 – 2033 (USD Billion)
- 9.18. Latin America
- 9.18.1 Latin America Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.18.1.1 Latin America Pharmaceutical Packagings Market, by Country, 2024 – 2033 (USD Billion)
- 9.18.1 Latin America Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.19 Latin America Pharmaceutical Packagings Market, by Type, 2024 – 2033
- 9.19.1 Latin America Pharmaceutical Packagings Market, by Type, 2024 – 2033 (USD Billion)
- 9.20 Latin America Pharmaceutical Packagings Market, by Material, 2024 – 2033
- 9.20.1 Latin America Pharmaceutical Packagings Market, by Material, 2024 – 2033 (USD Billion)
- 9.21 Latin America Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033
- 9.21.1 Latin America Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033 (USD Billion)
- 9.22 Latin America Pharmaceutical Packagings Market, by End Use, 2024 – 2033
- 9.22.1 Latin America Pharmaceutical Packagings Market, by End Use, 2024 – 2033 (USD Billion)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.23.1.1 The Middle-East and Africa Pharmaceutical Packagings Market, by Country, 2024 – 2033 (USD Billion)
- 9.23.1 The Middle-East and Africa Pharmaceutical Packagings Market, 2024 – 2033 (USD Billion)
- 9.24 The Middle-East and Africa Pharmaceutical Packagings Market, by Type, 2024 – 2033
- 9.24.1 The Middle-East and Africa Pharmaceutical Packagings Market, by Type, 2024 – 2033 (USD Billion)
- 9.25 The Middle-East and Africa Pharmaceutical Packagings Market, by Material, 2024 – 2033
- 9.25.1 The Middle-East and Africa Pharmaceutical Packagings Market, by Material, 2024 – 2033 (USD Billion)
- 9.26 The Middle-East and Africa Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033
- 9.26.1 The Middle-East and Africa Pharmaceutical Packagings Market, by Drug Delivery System, 2024 – 2033 (USD Billion)
- 9.27 The Middle-East and Africa Pharmaceutical Packagings Market, by End Use, 2024 – 2033
- 9.27.1 The Middle-East and Africa Pharmaceutical Packagings Market, by End Use, 2024 – 2033 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Amcor plc
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 AptarGroup Inc.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Becton
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Berry Global Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 CCL Industries Inc
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Comar LLC
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Dickinson and Company
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Drug Plastics Group
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Gerresheimer AG
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 International Paper
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 WestRock Company
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Owens Illinois Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Schott AG
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 SGD Pharma
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Vetter Pharma International
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 West Pharmaceutical Services Inc.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 Others
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.1 Amcor plc
List Of Figures
Figures No 1 to 38
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Amcor plc
- AptarGroup Inc.
- Becton
- Berry Global Inc.
- CCL Industries Inc
- Comar LLC
- Dickinson and Company
- Drug Plastics Group
- Gerresheimer AG
- International Paper
- Other Key Players
- Owens Illinois Inc.
- Schott AG
- SGD Pharma
- Vetter Pharma International
- West Pharmaceutical Services Inc.
- WestRock Company
- Others
FAQs
The restraints of the Pharmaceutical Packaging market are stringent regulations pertaining to usage of pharmaceutical packaging, less awareness about healthcare and pharmaceutical industries in many developing and underdeveloped countries.
The major drivers for the Pharmaceutical Packaging market is rapidly expanding healthcare and pharmaceutical industries across the globe, increasing production of generic and branded pharmaceuticals, growing geriatric population etc.
The “Primary Packaging” category dominated the market in 2022.
The key players in the market are Amcor plc, AptarGroup Inc., Becton, Berry Global Inc., CCL Industries Inc, Comar LLC, Dickinson and Company, Drug Plastics Group, Gerresheimer AG, International Paper, Other Key Players, Owens Illinois Inc., Schott AG, SGD Pharma, Vetter Pharma International, West Pharmaceutical Services Inc., WestRock Company, Others.
“North America” had the largest share in the Pharmaceutical Packaging Market.
The global market is projected to grow at a CAGR of 7.72% during the forecast period, 2023-2032.
The Pharmaceutical Packaging Market size was valued at USD 135.2 Billion in 2023.